Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection

By Levi R.   Arnon R.  

Vaccine, Vol. 14, Iss. 1, 1996-01 ,pp. : 85-92

Elsevier

Access to resources Recommend Favorite

DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice

By Lopez-Fuertes L.   Perez-Jimenez E.   Vila-Coro A.J.   Sack F.   Moreno S.   Konig S.A.   Junghans C.   Wittig B.   Timon M.   Esteban M.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 247-257

Elsevier

Access to resources Recommend Favorite

Protection against measles virus-induced encephalitis by antibodies from mice immunized intranasally with a synthetic peptide immunogen

By Hathaway L.J.   Obeid O.E.   Steward M.W.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 135-141

Elsevier

Access to resources Recommend Favorite

Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8 + T lymphocyte activation

By Rafati S.   Kariminia A.   Seyde-Eslami S.   Narimani M.   Taheri T.   Lebbatard M.  

Vaccine, Vol. 20, Iss. 19, 2002-06 ,pp. : 2439-2447

Elsevier

Access to resources Recommend Favorite

Candidate peptide vaccine induced protection against classical swine fever virus

By Dong X.-N.   Wei K.   Liu Z.-Q.   Chen Y.-H.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 167-173

Elsevier

Access to resources Recommend Favorite